Detalhe da pesquisa
1.
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Mult Scler;
26(14): 1866-1876, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31762387
2.
Motor neurone disease: progress and challenges.
Med J Aust;
206(8): 357-362, 2017 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28446118